XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.55

+0.1%

Dec 22 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (8395)	1/21/1999 2:21:00 AM
From: aknahow	Read Replies (1) of 17367

I had similar thoughts about slgonzalez post. I lived for 5 years in Paraguay. Supposedly in pharmacology many drugs have Guarani names. I have no objection to someone running trials on herbs. The Germans do do this. but I would hate to see the government say you can't take this until it has gone through P III trials. I understand the danger of people not seeking proper treatment because they think a drug will work. I still believe FDA should concentrate on safety only. I have no illusion that even FDA approved drugs work for everyone. We all know the difference between a placebos and an effective drug are not always that great, so why not speed up the process. I think that if a company sold drugs that were ineffective the market and law suits would penalize them, providing a real incentive for them to run meaningful trials which would provide information for doctors and patients. If doctors don't stay up on developments, as has been stated, there is no reason to suppose that we are any better off with FDA trials since this type of doctor may remain unaware of all the ramifications of even approved drugs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next